Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
120 participants
OBSERVATIONAL
2018-09-19
2020-01-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Spanish (Spain) Validation of a Specific Symptomatic Questionnaire for Patients With Nocturia
NCT01816724
Psychometric Testing of the Norwegian Version of the Comfort Behavioral Scale
NCT01181687
Pain in Competitive Athletes With Physical Disabilities: Techniques, Support and Perceived Difficulties
NCT05639842
Spanish Validation Frustration Discomfort Scale
NCT04238325
Graded Exposure Therapy in Chronic Pelvic Pain
NCT03590236
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Once each patient has signed the informed consent document and it has been verified that the inclusion criteria are met, it will be assigned an Identification Number (ID) that will relate it to your Medical Record (IDHC) by simple coding; The custody of the file with the relation of each ID with its HC will be borne by the principal investigator. Likewise, each observer will be assigned an identification number in order to blind the researcher who performs the statistical analysis. The patients included in the study will be evaluated, through the Spanish version of the CPS, by two of the researchers with an interval of 10 minutes between each evaluation, repeating this same procedure the next day. These evaluation sessions will be carried out throughout the treatment period, repeating on days 1, 15 and 28 of the period of admission of the included patients. Two researchers will evaluate the patients treated in the morning shift and the other two those treated in the afternoon shift of the Physiotherapy Service of the Guadarrama Hospital.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Management of the Contraversive Pushing Scale
Scale of evaluation of trunk control and pushing behavior in patients with stroke.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Male or female, ≥18 years of age at the time of consent.
* Have the diagnosis of ischemic or hemorrhagic hemispheric stroke without excluding other causes (surgery, cancer, etc ...).
* Enter for the first time in the Guadarrama Hospital to receive physiotherapy treatment.
Exclusion Criteria
18 Years
90 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Universidad Francisco de Vitoria
OTHER
Guadarrama Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
J. Nicolas Cuenca Zaldivar
Rehabilitation Service Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
J.Nicolas Cuenca Zaldivar
Role: PRINCIPAL_INVESTIGATOR
Guadarrama Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
J.Nicolas Cuenca Zaldivar
Guadarrama, Madrid, Spain
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
4.0
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.